Susquehanna Portfolio Strategies, LLC Ligand Pharmaceuticals Inc Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.58 Trillion
- Q2 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 1,791 shares of LGND stock, worth $362,641. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,791Holding current value
$362,641% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
306Shares Held
20MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$581 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$420 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$215 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$188 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$152 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.42B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...